Phase 2 Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have already taken part in one of two specific earlier studies (called 81201887MDG2001 or 81201887MDG1003) and received either the treatment JNJ-81201887 or a sham (inactive) procedure as part of that study
- You must be willing to sign a consent form showing you understand what the study involves and agree to take part (in some cases, a witness or legal representative may sign on your behalf, depending on local rules)
- Women who could become pregnant, men, and partners of male participants are not required to use contraception for this study
Who may not be able to join:
- There are no specific exclusion criteria listed for this study — meaning the researchers have not identified any particular reasons that would automatically prevent someone from joining (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Phone: 844-434-4210
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
4 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Number of Participants with Ocular and Systemic Treatment-emergent Adverse Events (TEAEs); Number of Participants with Abnormal Findings in Clinical Laboratory Assessments; Number of Participants with Abnormal Findings in Retinal imaging and Eye Examinations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.